Patients Outcomes of a Monofocal Intraocular Lens Designed for Monovision

Inclusion Criteria: * Signed informed consent * Availability to complete follow-up examinations up to 6 months after surgery * Cataract for which removal by phacoemulsification and subsequent IOL implantation was planned * CDVA was expected to be better than 20/30 (+0.18 logMAR) after IOL implantation * IOL power calculated in the range of +10.0 to +30.0 D * Corneal astigmatism \< 1.50 D * Candidate for refractive surgery in monovision configuration Exclusion Criteria: * Women who were pregnant, nursing or planning to become pregnant during the study * Difficulty for cooperation * Inability to provide informed consent * Concurrent participation in another investigational drug or device * History of ocular trauma * Previous intraocular or corneal surgery * Presence of ocular pathologies * Subjects with diagnosed degenerative visual disorders that were predicted to cause future acuity losses to a level of 20/30 or worse * Subjects who may be expected to require retinal laser treatment * Other eye condition that in the opinion of the investigator prevents the subject's participation in the study. * Any other condition that may be contraindicated according to the IOL Instructions for Use.